Preston Thomas J, Gomez Daniel, Olshove Vincent F, Phillips Alistair, Galantowicz Mark
Department of Cardiovascular Perfusion, The Heart Center at Nationwide Children's Hospital, Columbus, Ohio 43205, USA.
J Extra Corpor Technol. 2009 Dec;41(4):226-30.
The use of an arterial line filter (ALF) within the pediatric cardiopulmonary bypass (CPB) circuit is not a new concept. It has always presented the perfusionist with a circuit component that while valuable, increased prime volume. The purpose of this study was to evaluate the change in prime volume and emboli between a conventional oxygenator with separate ALF and a new generation oxygenator with integral arterial filter (AF). We performed a clinical, non-randomized retrospective evaluation of the Terumo Capiox RX15 (Terumo Cardiovascular Systems Corporation, Ann Arbor, MI) (n = 10) in conjunction with the Terumo Capiox AF125X ALF or the Capiox AF02 vs. the Terumo Capiox FX15 oxygenator with integral AF (n = 10). The above circuit components, in combination with the LUNA EDAC (emboli detection and classification) Quantifier (LUNA Innovations, Blacksburg, VA) were placed at various locations within each patient's CPB circuit to establish and quantify the presence and volume of gaseous emboli during all phases of cardiopulmonary bypass. The EDAC system is available/used for all patients undergoing CPB at this institution. When compared to a more conventional CPB circuit, the Capiox FX15 primes more easily as it does not require a carbon dioxide flush while still providing a 32 microm AF. There was no statistical difference in air handling between the tested oxygenators and their associated circuits. During this review it was determined that use of the Capiox FX15 simplifies the arterial limb of the pediatric CPB circuit. Removal of the separate ALF led to the removal of several, now unnecessary, arterial connectors and additional tubing (arterial line filter bypass). Removal of these components led to a reduction in prime volume and decreased the hemodilutional effect. The FX15 provided a safe, simplified pediatric CPB circuit and was as effective in gaseous microemboli removal as was the more traditional RX15 with separate ALF during this review.
在小儿体外循环(CPB)回路中使用动脉管路过滤器(ALF)并非新概念。它一直是灌注师面对的一种回路组件,虽有价值,但会增加预充量。本研究的目的是评估传统带独立ALF的氧合器与新一代带一体式动脉过滤器(AF)的氧合器之间预充量和栓子的变化。我们对泰尔茂Capiox RX15(泰尔茂心血管系统公司,密歇根州安阿伯)(n = 10)联合泰尔茂Capiox AF125X ALF或Capiox AF02与带一体式AF的泰尔茂Capiox FX15氧合器(n = 10)进行了临床、非随机回顾性评估。上述回路组件与LUNA EDAC(栓子检测与分类)定量仪(LUNA创新公司,弗吉尼亚州布莱克斯堡)一起放置在每位患者CPB回路的不同位置,以确定并量化体外循环各阶段气态栓子的存在情况和体积。该机构所有接受CPB的患者均可使用EDAC系统。与更传统的CPB回路相比,Capiox FX15更容易预充,因为它不需要二氧化碳冲洗,同时仍能提供32微米的AF。测试的氧合器及其相关回路在空气处理方面没有统计学差异。在本次评估过程中发现,使用Capiox FX15简化了小儿CPB回路的动脉分支。去除独立的ALF导致去除了几个现在不再需要的动脉连接器和额外的管路(动脉管路过滤器旁路)。去除这些组件导致预充量减少,并降低了血液稀释效果。在本次评估中,FX15提供了一个安全、简化的小儿CPB回路,在去除气态微栓子方面与更传统的带独立ALF的RX15一样有效。